Michael Frimpong

1.0k total citations
43 papers, 426 citations indexed

About

Michael Frimpong is a scholar working on Epidemiology, Small Animals and Infectious Diseases. According to data from OpenAlex, Michael Frimpong has authored 43 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 17 papers in Small Animals and 13 papers in Infectious Diseases. Recurrent topics in Michael Frimpong's work include Mycobacterium research and diagnosis (27 papers), Infectious Diseases and Mycology (17 papers) and Infectious Diseases and Tuberculosis (5 papers). Michael Frimpong is often cited by papers focused on Mycobacterium research and diagnosis (27 papers), Infectious Diseases and Mycology (17 papers) and Infectious Diseases and Tuberculosis (5 papers). Michael Frimpong collaborates with scholars based in Ghana, United Kingdom and Germany. Michael Frimpong's co-authors include Richard Odame Phillips, Mark Wansbrough‐Jones, Fred Stephen Sarfo, Issaka Maman, Kabiru Mohammed Abass, Yaw Ampem Amoako, Earnest Njih Tabah, Edwin Ampadu, Rachel L. Pullan and H Simpson and has published in prestigious journals such as PLoS ONE, Scientific Reports and Emerging infectious diseases.

In The Last Decade

Michael Frimpong

37 papers receiving 423 citations

Peers

Michael Frimpong

EPIDE

SURGE

Chris Coulter Australia

Harjeet Singh Virk Netherlands

Natalie Williams‐Bouyer United States

Christine Bonnal France

Gabriela Ibáñez-Cervantes Mexico

Anna Grancini Italy

Godwin Wilson Qatar

Cristina Toscano Portugal

Emmanuelle Bergeron France

Georgia Vrioni Greece

Chris Coulter Australia

Michael Frimpong

381 ×1.6

EPIDE

269 ×1.4

151 ×1.1

75 ×1.7

SURGE

81 ×2.1

Citations per year, relative to Michael Frimpong Michael Frimpong (= 1×) peers Chris Coulter

Countries citing papers authored by Michael Frimpong

Since Specialization

Citations

This map shows the geographic impact of Michael Frimpong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Frimpong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Frimpong more than expected).

Fields of papers citing papers by Michael Frimpong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Frimpong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Frimpong. The network helps show where Michael Frimpong may publish in the future.

Co-authorship network of co-authors of Michael Frimpong

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Frimpong. A scholar is included among the top collaborators of Michael Frimpong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Frimpong. Michael Frimpong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frimpong, Michael, et al.. (2024). Clinical and microbiological predictors of healing in Buruli ulcer disease. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 34. 100415–100415. 2 indexed citations

Okuni, Julius Boniface, Yakhya Dièye, Michael Frimpong, et al.. (2023). OA-322 Bridging the research gaps on AMR in sub-Saharan Africa – A one health approach. A12.1–A12. 1 indexed citations

Baird, Mark S., et al.. (2023). A single synthetic lipid antigen for improved serological diagnosis of Buruli ulcer. Public Health Action. 13(4). 173–178. 1 indexed citations

Marion, Estelle, Sundeep Chaitanya Vedithi, Dissou Affolabi, et al.. (2022). A combined effort of 11 laboratories in the WHO African region to improve quality of Buruli ulcer PCR diagnosis: The “BU-LABNET”. PLoS neglected tropical diseases. 16(11). e0010908–e0010908. 10 indexed citations

Amoako, Yaw Ampem, et al.. (2021). Mental health and quality of life burden in Buruli ulcer disease patients in Ghana. Infectious Diseases of Poverty. 10(1). 109–109. 20 indexed citations

Amoako, Yaw Ampem, et al.. (2021). Caregiver burden in Buruli ulcer disease: Evidence from Ghana. PLoS neglected tropical diseases. 15(6). e0009454–e0009454. 12 indexed citations

Owusu, Michael, Augustina Angelina Sylverken, Philip El‐Duah, et al.. (2021). Low risk of SARS-CoV-2 in blood transfusion. PLoS ONE. 16(4). e0249069–e0249069. 11 indexed citations

Frimpong, Michael, et al.. (2021). Evaluation of a real-time recombinase polymerase amplification assay for rapid detection of Schistosoma haematobium infection in resource-limited setting. Acta Tropica. 216. 105847–105847. 11 indexed citations

Amoako, Yaw Ampem, Michael Frimpong, Edwin Ampadu, et al.. (2021). Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana. BMC Infectious Diseases. 21(1). 331–331. 1 indexed citations

10.

Frimpong, Michael, et al.. (2020). Multiplex Recombinase Polymerase Amplification Assay for Simultaneous Detection of Treponema pallidum and Haemophilus ducreyi in Yaws-Like Lesions. Tropical Medicine and Infectious Disease. 5(4). 157–157. 5 indexed citations

11.

Frimpong, Michael, et al.. (2020). Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana. PLoS neglected tropical diseases. 14(5). e0008369–e0008369. 7 indexed citations

12.

Frimpong, Michael, Yaw Ampem Amoako, Richmond Yeboah, et al.. (2020). Diagnostics for COVID-19: A case for field-deployable, rapid molecular tests for community surveillance. Ghana Medical Journal. 54(4s). 71–76. 3 indexed citations

13.

Frimpong, Michael, et al.. (2019). Inter-Laboratory Comparability of Clinical Chemistry Testing: A New Perspective. International Journal of Sciences: Basic and Applied Research. 48(5). 196–207.

14.

Simpson, H, Kebede Deribe, Earnest Njih Tabah, et al.. (2019). Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus. The Lancet Global Health. 7(7). e912–e922. 42 indexed citations

15.

Barogui, Yves Thierry, Kabiru Mohammed Abass, Michael Frimpong, et al.. (2019). Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa. PLoS neglected tropical diseases. 13(10). e0007866–e0007866. 5 indexed citations

16.

Frimpong, Michael, Fred Stephen Sarfo, Kabiru Mohammed Abass, et al.. (2018). IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients withMycobacterium ulceransinfection. PeerJ. 6. e5294–e5294. 6 indexed citations

17.

Frimpong, Michael, Marcus Beißner, Ken Laing, et al.. (2017). Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay. PLoS neglected tropical diseases. 11(7). e0005695–e0005695. 17 indexed citations

18.

Frimpong, Michael, Ohene Opare‐Sem, Betty Norman, et al.. (2016). High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana. International Journal of Mycobacteriology. 5(2). 226–230. 26 indexed citations

19.

Phillips, Richard Odame, Michael Frimpong, Fred Stephen Sarfo, et al.. (2014). Infection withMansonella perstansNematodes in Buruli Ulcer Patients, Ghana. Emerging infectious diseases. 20(6). 1000–1003. 10 indexed citations

20.

Phillips, Richard Odame, Fred Stephen Sarfo, Jordi Landier, et al.. (2014). Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease. PLoS neglected tropical diseases. 8(4). e2786–e2786. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact